Immunologic monitoring of cellular immune responses in cancer vaccine therapy

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Tsang, Kwong Yok ^c   Whiteside, Theresa L ^a   Gulley, James L ^b   Clay, Timothy M ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; POXVIRUS VACCINE; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIGEN SPECIFICITY; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CASTRATION RESISTANT PROSTATE CANCER; CELL POPULATION; CELLULAR IMMUNITY; DISEASE FREE SURVIVAL; EDITORIAL; HUMAN; IMMUNOCOMPETENCE; LYMPH NODE; LYMPHOCYTE FUNCTION; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROGNOSIS; PROSTATE CANCER; REGULATORY T LYMPHOCYTE; SOLID TUMOR; SUPPRESSOR CELL; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; VACCINATION; CLINICAL TRIAL (TOPIC); IMMUNOLOGICAL MONITORING; IMMUNOLOGY; IMMUNOTHERAPY; MACROPHAGE; METHODOLOGY; NEOPLASM;

CANCER VACCINES; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; MACROPHAGES; MONITORING, IMMUNOLOGIC; NEOPLASMS; T-LYMPHOCYTES;

EID: 80052674932     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/370374     Document Type: Editorial

References (9)

1. Vergati M., Cereda V., Madan R. A., Gulley J. L., Huen N.-Y., Rogers C. J., Hance K. W., Arlen P. M., Schlom J., Tsang K. Y., Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination Cancer Immunology, Immunotherapy 2011 60 2 197 206
2. Gulley J. L., Arlen P. M., Madan R. A., Tsang K. Y., Pazdur M. P., Skarupa L., Jones J. L., Poole D. J., Higgins J. P., Hodge J. W., Cereda V., Vergati M., Steinberg S. M., Haiabi S., Jones E., Chen C., Parnes H., Wright J. J., Dahut W. L., Schlom J., Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer Cancer Immunology, Immunotherapy 2010 59 5 663 674
3. Filipazzi P., Valenti R., Huber V., Pilla L., Canese P., Iero M., Castelli C., Mariani L., Parmiani G., Rivoltini L., Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine Journal of Clinical Oncology 2007 25 18 2546 2553 (Pubitemid 47041228)
4. Vuk-Pavlovi S., Bulur P. A., Lin YI., Qin R., Szumlanski C. L., Zhao X., Dietz A. B., Immunosuppressive CD14+HLA-DR monocytes in prostate cancer Prostate 2010 70 4 443 455
5. Koide N., Nishio A., Sato T., Sugiyama A., Miyagawa S. I., Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus American Journal of Gastroenterology 2004 99 9 1667 1674 (Pubitemid 39237489)
6. Hanada T., Nakagawa M., Emoto A., Nomura T., Nasu N., Nomura Y., Prognostic value of tumor-associated macrophage count in human bladder cancer International Journal of Urology 2000 7 7 263 269 (Pubitemid 30440592)
7. Ohno S., Ohno Y., Suzuki N., Kamei T., Koike K., Inagawa H., Kohchi C., Soma G. I., Inoue M., Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer Anticancer Research 2004 24 5 3335 3342 (Pubitemid 39390949)
8. Zhang B. C., Gao J., Wang J., Rao Z. G., Wang B. C., Gao J. F., Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma Medical Oncology
9. Butterfield L., Palucka A., Britten C., Recommendations from the iSBTc-SITC/FDA/NCI workshop on immunotherapy biomarkers Clinical Cancer Research 2011 17 10 3064 3076